News

The US Food and Drug Administration has approved nipocalimab-aahu, a new FcRn- blocking monoclonal antibody, for the treatment of generalized myasthenia gravis.
El número de incidentes antisemitas denunciados aumentó de 108 en 2023 a 139 en 2024, según la Liga Antidifamación d.
Nipocalimab-aahu is a human immunoglobulin G1 monoclonal antibody that binds with high affinity to the neonatal Fc receptor, resulting in the reduction of circulating IgG levels.
Saturday Night Live monologue was almost very different, he said, because show boss Lorne Michaels—and the network censor— ...
UN Watch is calling on Secretary of State Marco Rubio to sanction and deny entry and visa access to UN Special Rapporteur ...
Critics see the terminations as an effort to politicize the Holocaust museum. The White House says Trump will appoint new ...
The FDA has approved a monoclonal antibody to treat individuals aged 12 years and older with generalized myasthenia gravis ...
Approval is based on results from the pivotal Vivacity-MG3 trial in which IMAAVY (nipocalimab-aahu) demonstrated superior ...
The FDA approved nipocalimab (Imaavy) injection to treat adults and children ages 12 and older with generalized myasthenia ...
The debate in Philadelphia over a recent report from the Anti-Defamation League reflects a national conversation happening this week in the Senate.
Kotak Alternate Asset Managers (Kotak Alts) on Wednesday announced a Rs 1,200-crore investment in CNC machine maker Ace Designers. The funding will help the 1979-founded company set up a new ...
Kotak Alternate Asset Managers invests Rs 1,200 crore in CNC machine maker Ace Designers, boosting the company's ...